drugset / Trial / NCT00222521
Insulin Glargine Vs Standard Insulin Therapy
Phase 3
Completed
20 enrolled
University of Minnesota
Moran, Antoinette, M.D. · collabSanofi · collab
RandomizedCrossoverOpen-labelTreatment
Summary
This Study is designed to determine whether treatment of CFRD with glargine insulin will improve hemoglobin A1c, weight and muscle mass compared to the traditional regimen of bedtime NPH insulin.
Timeline
- Start
- 2003-04
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin glargine | Protein / enzyme biologic | — | — |